Poorya Hosseini
Private-Equity-Analyst bei Flagship Pioneering
Profil
Poorya Hosseini is the founder of Cellarity Inc. (2017) and Generate Biomedicines, Inc. (2018).
He currently holds positions as an Associate at Flagship Pioneering, a Partner at Danhua Capital Management LLC, and a Partner at Camford Capital (since 2021).
Mr. Hosseini has a graduate degree from McGill University and a doctorate degree from Massachusetts Institute of Technology.
Aktive Positionen von Poorya Hosseini
Unternehmen | Position | Beginn |
---|---|---|
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private-Equity-Analyst | - |
Camford Capital
Camford Capital Investment ManagersFinance Camford Capital is a venture capital firm founded in 2013. The firm is headquartered in Palo Alto, California. | Private Equity Investor | 01.03.2021 |
Danhua Capital Management LLC
Danhua Capital Management LLC Investment ManagersFinance Danhua Capital Management LLC (Danhua Capital Management) is a venture capital firm founded in 2013 by Andrew Gu. The firm is headquartered in Palo Alto, California. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Poorya Hosseini
Unternehmen | Position | Ende |
---|---|---|
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Gründer | 28.02.2021 |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Gründer | 28.02.2021 |
Ausbildung von Poorya Hosseini
McGill University | Graduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Camford Capital
Camford Capital Investment ManagersFinance Camford Capital is a venture capital firm founded in 2013. The firm is headquartered in Palo Alto, California. | Finance |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Health Technology |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Danhua Capital Management LLC
Danhua Capital Management LLC Investment ManagersFinance Danhua Capital Management LLC (Danhua Capital Management) is a venture capital firm founded in 2013 by Andrew Gu. The firm is headquartered in Palo Alto, California. | Finance |